Nelson Dusetti on personalized chemotherapy for pancreatic cancer at Jeudi du PSCC
Nelson Dusetti, Head of the Department of Translational Research and Innovative Therapies at CRCM, shared a post on LinkedIn:
“This March 20, 2025, from 16:30, I will be at Jeudi du Paris Saclay Cancer Cluster (PSCC) #15: Recent Advances and New Developments in Pancreatic Cancer, I will have the opportunity to present our latest research to industry stakeholders, fostering collaborations that can accelerate the clinical application of innovative treatment strategies.
I will discuss ‘Personalized Chemotherapy Approaches in Pancreatic Cancer’, showcasing how AI-driven intratumoral heterogeneity deconvolution and preclinical models can refine treatment selection and improve patient outcomes.
This event provides a unique platform to exchange ideas with industrial partners and explore opportunities for translating research into clinical practice.
I am honored to share this session with esteemed colleagues:
- Pr. Pascal Hammel (AP-HP)
- Dr. Raphaël Rodriguez (CNRS, Curie Institute)
I invite you to join the discussion, share your insights, and explore how we can work together to bring new solutions to pancreatic cancer treatment. Looking forward to seeing you there!”
More posts featuring Nelson Dusetti.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023